Pfizer Agrees to Settle Prempro Lawsuits

AVVO February 11, 2011 Drugmaker Pfizer Incorporated has agreed to settle more than 2,200 lawsuits filed against its Wyeth unit over its hormone replacement drug Prempro. A company spokesman told Bloomberg News that Pfizer will pay $330 million over claims that Prempro caused breast cancer. More than 6 million women reportedly took the drug, which Continue Reading …

Bio-identical hormone therapy raising flags

CBC News
Canada

Last Updated: Friday, February 11, 2011 | 12:13 PM ET

Some doctors in Canada are warning women that they are courting risks they may not even be aware of when they turn to bio-identical hormone replacement therapy to treat the symptoms of menopause.

Breaking News: Pfizer ordered to pay millions in PremPro cases

Society for Menstrual Cycle Research
re: Cycling

February 8th, 2011 by Elizabeth Kissling

Pfizer, which now owns Wyeth’s PremPro synthetic progestin-estrogen combination that was widely taken for relief of discomforts that sometimes accompany menopause, has been ordered to pay damages in two separate cases this week.

Timing of HRT Influences Breast Cancer Risk

Uncertainty about estrogen alone
Medscape Today

Nick Mulcahy
January 31, 2011

January 31, 2011 — Breast cancer risk associated with combination hormone replacement therapy (HRT) is greater if the therapy is started soon after menopause, according to the results of the observational Million Women Study conducted in the United Kingdom.

Why Almost Everything You Hear About Medicine Is Wrong

Newsweek

January 24, 2011

If you follow the news about health research, you risk whiplash. First garlic lowers bad cholesterol, then—after more study—it doesn’t. Hormone replacement reduces the risk of heart disease in postmenopausal women, until a huge study finds that it doesn’t (and that it raises the risk of breast cancer to boot). Eating a big breakfast cuts your total daily calories, or not—as a study released last week finds. Yet even if biomedical research can be a fickle guide, we rely on it.

Healthbeat: Is your diet giving you a headache?

Seacoast Online
Maine
January 16, 2011 2:00 AM

Survey research tells us that close to 100 percent of people experience a headache some time in their life. There are many types of headaches and therefore many causes. The most common is a tension-type headache (not surprising). Migraines represent about 13 percent of all headaches, with women three times more likely than men to get this form.

Estrogen May Play Role in Rising Rates of Head, Neck Cancer

HealthDay News

TUESDAY, Jan. 4 — Rates of head and neck cancer are rising among some groups of people, including young women without any known risk factors. Now, a study suggests that estrogen may help the cancer spread by boosting the movement of precancerous cells in the mouth.
Click here to find out more!Previous research found that the body changes how it handles estrogen after the lungs are exposed to smoke. This may lead to lung cancer.

What To Do About Big Pharma And The “Sick Care” Industry

Retire World

Written By admin
January 2011

This post reflects our ideology at Retire Worldwide that the so-called “health care” industry run by Big Pharma is at least as damaging to the physical health of our society as the Banksters on Wall Street are to our personal finances.

1991-2010 Enormous Scale of Pharma Criminal Fraud Settlements

Alliance for Human Research Protection

Friday, 24 December 2010

From 1991-2000 qui tam law suits accounted for only 9% of settlements with the government. But from 2001-2010, qui tam settlements comprised 67% of the billions in payouts

A report by Public Citizen documents the enormous scale of pharmaceutical industry lawless activities during the past two decades–crimes that resulted in a minimum of $1 million in penalties paid to the government.

Menopause and PMDD: Update and new approaches

Bytemed.com
December 2010

Menopausal women can add whiplash to the laundry list of medical issues they face at midlife. The medical profession has done an about-face in their recommendations for hormone replacement therapy (HRT).